Symptomatic treatment of anxiety states with dominant symptoms: anxiety, internal anxiety, stress. Medications that affect the nervous system. Anxiolytics.
Composition and form of release
Spitomin is produced in pill form. The active ingredient is buspirone hydrochloride 10 mg.
Spitomin is used in the treatment of:
- panic disorder;
- generalized anxiety disorders (GAD);
- autonomic dysfunction syndrome;
- depressive disorders (as part of complex treatment);
- alcohol withdrawal syndrome.
The use of Spitomin is impossible with increased sensitivity to buspirone hydrochloride, severe renal failure, severe hepatic failure, glaucoma, pregnancy, myasthenia gravis. The drug is used in pediatric practice, as it is not intended for the treatment of patients under 18 years of age.
In addition, Spitomin is not prescribed to patients who receive therapy with MAO inhibitors or within 14 days after stopping them.
Spitomin is prescribed with caution to patients with liver cirrhosis and renal failure.
Application during pregnancy and lactation
Due to the fact that there have been no controlled clinical studies regarding the use of buspirone hydrochloride during pregnancy, the appointment of Spitomin during this period is possible only in extreme cases. During therapy with Spitomin, a woman of childbearing age should use reliable methods of contraception, since the safety of the drug for the fetus has not been confirmed.
Buspirone penetrates into breast milk, therefore, if it is necessary to prescribe Spitomin to a lactating woman, it is necessary to refuse feeding.
Method of administration and dosage
Spitomin must be taken orally, preferably after meals at the same time.
The drug is not intended for the episodic elimination of feelings of anxiety, since the maximum therapeutic effect can be obtained only with repeated use of the drug.
The dose of the drug is selected individually. The starting dose of the drug is 15 mg, however, if necessary, it may be increased by 5 mg every knock every 2 or 3 days. To obtain the maximum therapeutic effect, the daily dose is divided into 2 or 3 doses. The highest single dose is 30 mg, the daily dose is 60 mg.
When taking Spitomin in high doses, the patient develops gastrointestinal disorders, dizziness, increased drowsiness, depression of consciousness.
In case of drug poisoning, the patient is rinsed with the stomach and prescribed appropriate treatment.
When taking Spitomin, the patient may develop fainting, cerebrovascular accident, decompensated heart failure, myocardial infarction, headaches, sleep disturbances, depersonalization, euphoria, fear, hallucinations, suicidal thoughts, epileptic seizures, cold intolerance, stuttering, extrapyramidal disorders ears, swelling of the nasal mucosa, blurred vision, redness of the eyes, impaired taste and smell, eye pain, thyroid damage, flatulence, increased appetite, and diarrhea.
Storage conditions and periods
Spitomin should be stored in places inaccessible to children, which are impervious to light. The storage period is 5 years.